HC-070

anti-anxiety agent; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Hypersensitivity (Allergy) 02/08/2023 - "HC-070 also had a significant anti-hypersensitivity effect in the established phase of the CCI model. " 02/08/2023 - "Inhibition of Canonical Transient Receptor Potential Channels 4/5 with Highly Selective and Potent Small-Molecule HC-070 Alleviates Mechanical Hypersensitivity in Rat Models of Visceral and Neuropathic Pain." 06/14/2022 - "TRPC4/C5 antagonist ML-204 had a weak antihypersensitivity effect that was only in the early phase, whereas TRPC4/C5 antagonist HC-070 had no effect on hypersensitivity induced by netrin-1. "
2.	Neuralgia (Stump Neuralgia) 02/08/2023 - "Inhibition of Canonical Transient Receptor Potential Channels 4/5 with Highly Selective and Potent Small-Molecule HC-070 Alleviates Mechanical Hypersensitivity in Rat Models of Visceral and Neuropathic Pain."

1.	Transient Receptor Potential Channels
2.	Netrin-1
3.	ML 204